Varlilumab
Varlilumab (pronounced var-li-lu-mab) is a type of monoclonal antibody that is being studied in the treatment of certain types of cancer. It is a type of immune checkpoint inhibitor.
Pronunciation
The pronunciation of Varlilumab is "var-li-lu-mab".
Etymology
The name Varlilumab is derived from the Latin roots "varli" meaning "variety" and "lumab" meaning "light". This is in reference to the drug's ability to target a variety of cancer cells and "light" the way for the immune system to attack them.
Related Terms
- Monoclonal Antibody: A type of protein made in the laboratory that can bind to substances in the body, including cancer cells. Varlilumab is a type of monoclonal antibody.
- Immune Checkpoint Inhibitor: A type of drug that blocks certain proteins made by some types of immune system cells, such as T cells, and some cancer cells. These proteins help keep immune responses in check and can keep T cells from killing cancer cells. When these proteins are blocked, the "brakes" on the immune system are released and T cells are able to kill cancer cells better. Varlilumab is a type of immune checkpoint inhibitor.
- Cancer: A term for diseases in which abnormal cells divide without control and can invade nearby tissues. Cancer cells can also spread to other parts of the body through the blood and lymph systems.
See Also
External links
- Medical encyclopedia article on Varlilumab
- Wikipedia's article - Varlilumab
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski